Skip to main content
Top
Published in: Rheumatology International 3/2008

01-01-2008 | Case Report

Central nervous system involvement as a major manifestation of rheumatoid arthritis

Authors: M. Zolcinski, S. Bazan-Socha, G. Zwolinska, J. Musial

Published in: Rheumatology International | Issue 3/2008

Login to get access

Abstract

A 58-year-old woman with an 8-year history of seropositive rheumatoid arthritis was admitted with right hemiparesis, history of seizures, fever, weight loss and headaches. Her blood tests revealed the presence of rheumatoid factor, elevated C-reactive protein and anti-cyclic citrullinated peptide antibodies (>200 RU/ml). Examination of cerebrospinal fluid demonstrated pleocytosis (118 cells/mm3, predominantly lymphocytes) with elevated protein level (58 mg/dl); cultures were negative. Magnetic resonance imaging findings were suggestive for meningoencephalitis. Short course of high-dose corticosteroids and cyclophosphamide led to clinical improvement. Rheumatoid vasculitis was probably responsible for neurological symptoms.
Literature
1.
go back to reference Harris ED (2005) Clinical features of rheumatoid arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (eds) Kelley’s textbook of rheumatology. Elsevier, Philadelphia, pp 1043–1078 Harris ED (2005) Clinical features of rheumatoid arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (eds) Kelley’s textbook of rheumatology. Elsevier, Philadelphia, pp 1043–1078
2.
go back to reference Matteson EL, Cohen MD, Conn DL (2000) Rheumatoid arthritis. Clinical features and systemic involvement. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, St Louis, pp 5.4.1–5.4.8 Matteson EL, Cohen MD, Conn DL (2000) Rheumatoid arthritis. Clinical features and systemic involvement. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, St Louis, pp 5.4.1–5.4.8
3.
go back to reference Luqmani RA, Pathare S, Kwok-Fai TL (2005) How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 19:321–336PubMedCrossRef Luqmani RA, Pathare S, Kwok-Fai TL (2005) How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 19:321–336PubMedCrossRef
5.
go back to reference Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M (2001) Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. Rheumatol Int 20:43–47PubMedCrossRef Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M (2001) Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. Rheumatol Int 20:43–47PubMedCrossRef
6.
go back to reference Tajima Y, Kishimoto R, Sudoh K, Matsumoto A (2004) Multiple central nervous system lesions associated with rheumatoid arthritis. Arch Neurol 61:1794–1795PubMedCrossRef Tajima Y, Kishimoto R, Sudoh K, Matsumoto A (2004) Multiple central nervous system lesions associated with rheumatoid arthritis. Arch Neurol 61:1794–1795PubMedCrossRef
7.
go back to reference Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288PubMedCrossRef Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288PubMedCrossRef
8.
go back to reference Neamtu L, Belmont M, Miller DC, Leroux P, Weinberg H, Zagzag D (2001) Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology 56:814–815PubMed Neamtu L, Belmont M, Miller DC, Leroux P, Weinberg H, Zagzag D (2001) Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology 56:814–815PubMed
9.
go back to reference Karam NE, Roger L, Hankins LL, Reveille JD (1994) Rheumatoid nodulosis of the meninges. J Rheumatol 21:1960–1963PubMed Karam NE, Roger L, Hankins LL, Reveille JD (1994) Rheumatoid nodulosis of the meninges. J Rheumatol 21:1960–1963PubMed
10.
go back to reference Scott DG, Bacon PA (1984) Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76:377–384PubMedCrossRef Scott DG, Bacon PA (1984) Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76:377–384PubMedCrossRef
11.
go back to reference Walters MT, Cawley MI (1988) Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate. Ann Rheum Dis 47:924–929PubMedCrossRef Walters MT, Cawley MI (1988) Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate. Ann Rheum Dis 47:924–929PubMedCrossRef
Metadata
Title
Central nervous system involvement as a major manifestation of rheumatoid arthritis
Authors
M. Zolcinski
S. Bazan-Socha
G. Zwolinska
J. Musial
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0428-0

Other articles of this Issue 3/2008

Rheumatology International 3/2008 Go to the issue